$BCRX BIOCRYST PHARMACEUTICALS INC Insider Trading
Get free email notifications about insider trading in BIOCRYST PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOCRYST PHARMACEUTICALS INC. Insider overview, share value development, latest insider transactions and email notifications about new events in BIOCRYST PHARMACEUTICALS INC for free.
IRS Number: 621413174
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: BCRX
Company Address: 4505 EMPEROR BOULEVARD SUITE 200 DURHAM 27703
BioCryst Pharmaceuticals, Inc. is a commercial-stage biotechnology company that discovers novel, oral, and small-molecule medicines. The firm focuses on the treatment of rare diseases in which unmet medical needs exist and an enzyme in the biological pathway of the disease. Its programs include BCX9930, an oral Factor D inhibitor for the treatment of complement-mediated diseases, BCX9250, an ALK-2 inhibitor for the treatment of fibrodysplasia ossificans progressiva, and galidesivir, a potential treatment for marburg virus disease and yellow fever. The company was founded in 1986 and is headquartered in Durham, NC.
Market Capitalization: $427.06M
Prev close: $5.67
Average Daily Volume: 981,787
Days Low: $5.55
Year Low: $1.63
Year High: $7.56
BIOCRYST PHARMACEUTICALS INC Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 01 2021 | BCRX | BIOCRYST PHARMACEU ... | HEGGIE THERESA | Director | Grant | A | 15.77 | 317 | 4,999 | 14,166 | 13.8 K to 14.2 K (+2.29 %) |
| May 13 2021 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Chief Legal Officer | Option Exercise | M | 4.73 | 35,852 | 169,580 | 0 | |
| May 13 2021 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Chief Legal Officer | Option Exercise | M | 4.73 | 35,852 | 169,580 | 0 | |
| May 13 2021 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Chief Legal Officer | Option Exercise | M | 5.45 | 68,000 | 370,600 | 0 | |
| May 13 2021 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Chief Legal Officer | Option Exercise | M | 5.45 | 68,000 | 370,600 | 0 | |
| May 13 2021 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Chief Legal Officer | Option Exercise | M | 1.42 | 33,132 | 47,047 | 0 | |
| May 13 2021 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Chief Legal Officer | Option Exercise | M | 1.42 | 33,132 | 47,047 | 0 | |
| May 13 2021 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Chief Legal Officer | Option Exercise | M | 4.73 | 1,648 | 7,795 | 35,852 | |
| May 13 2021 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Chief Legal Officer | Option Exercise | M | 4.73 | 1,648 | 7,795 | 35,852 | |
| May 13 2021 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Chief Legal Officer | Buy | M | 4.73 | 35,852 | 169,580 | 146,127 | 110.3 K to 146.1 K (+32.51 %) |
| May 13 2021 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Chief Legal Officer | Buy | M | 4.73 | 35,852 | 169,580 | 146,127 | 110.3 K to 146.1 K (+32.51 %) |
| May 13 2021 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Chief Legal Officer | Sell | S | 12.04 | 102,780 | 1,237,471 | 110,275 | 213.1 K to 110.3 K (-48.24 %) |
| May 13 2021 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Chief Legal Officer | Sell | S | 12.04 | 102,780 | 1,237,471 | 110,275 | 213.1 K to 110.3 K (-48.24 %) |
| May 13 2021 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Chief Legal Officer | Buy | M | 5.45 | 68,000 | 370,600 | 213,055 | 145.1 K to 213.1 K (+46.88 %) |
| May 13 2021 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Chief Legal Officer | Buy | M | 5.45 | 68,000 | 370,600 | 213,055 | 145.1 K to 213.1 K (+46.88 %) |